van der Veldt, A A M <br/><br/>
[Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer].  [electronic resource] 

 -  Nederlands tijdschrift voor geneeskunde  May 2007 
 - 1142-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0028-2162 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--adverse effects<br/>Safety<br/>Sunitinib<br/>Treatment Outcome